Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide range of cancers has come unstuck. | Monte Rosa ...

Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, has published a peer-reviewed study highlighting a potential breakt ...

Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET. Company Participants. Andrew Funderburk - Senior Vice President, Investor Re ...

Nell Zink’s latest novel, “Sister Europe,” is both an extraordinary encapsulation of the empty, performative morality that ...

There were more weanling bulls than usual at Iveragh Mart's spring bull and bullock show and sale this week and trade was red ...